Article

Drug delivery firm hires medical expert

Evry, France—Novagali Pharma, a drug delivery specialty company using cationic emulsions to develop age-related macular degeneration treatments, has hired Florence Barouki-Binlich, MD, as its vice president for development and medical affairs.

Evry, France-Novagali Pharma, a drug delivery specialty company using cationic emulsions to develop age-related macular degeneration treatments, has hired Florence Barouki-Binlich, MD, as its vice president for development and medical affairs.

Dr. Barouki-Binlich will be responsible for all stages of pharmaceutical development, including regulatory affairs, preclinical and clinical research, finding investigators, and analyzing results. Her appointment comes as the company prepares to launch preclinical and clinical trials in ophthalmology (cyclosporine formulations) and oncology.

She most recently spent 4 years at Bayer Pharma (France), where she headed the company's Therapeutic Group.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.